Several recent studies show that antizyme inhibitor 1 (AZIN1) is one of the most common A-to-I RNA alterations in various cancer types, including hepatocellular carcinoma [2], non-small cell lung cancer [4], colorectal cancer (CRC) [5]. This evidence concerns the gene AZIN1 and colorectal carcinoma.